Revolutionizing Cancer Care: Next-Gen Engineering and Policy Synergy for a Cure-Driven Future

Abstract

Major engineering advances synthetic biology, precision genome editing, nanotechnology, advanced biomaterials, scalable manufacturing, and artificial intelligence are converging to enable therapeutic paradigms that could shift oncology from long-term disease control toward durable cures. Yet technical breakthroughs alone are insufficient. Realizing care-driven care at scale requires adaptive regulatory frameworks, outcome-linked financing models, federated data governance, manufacturing policy for decentralized production, and equity-centered implementation. This paper synthesizes the engineering frontier, maps translational bottlenecks, and proposes a practical policy-aware translational ecosystem the Cure-Driven Partnership Model (CDPM) to accelerate safe, ethical, and equitable deployment of curative cancer interventions. We conclude with prioritized research objectives, governance recommendations, and an implementation checklist for stakeholders.